DECIPHERA PHARMACEUTICALS IN - COM (DCPH)

CUSIP: 24344T101

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM
Total 13F shares
56,212,844
Share change
-1,622,308
Total reported value
$792,074,465
Put/Call ratio
90%
Price per share
$14.08
Number of holders
143
Value change
-$25,997,353
Number of buys
69
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 24344T101?
CUSIP 24344T101 identifies DCPH - DECIPHERA PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of DECIPHERA PHARMACEUTICALS IN - COM (DCPH) as of Q2 2023

As of 30 Jun 2023, DECIPHERA PHARMACEUTICALS IN - COM (DCPH) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,212,844 shares. The largest 10 holders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BlackRock Inc., Redmile Group, LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BRAIDWELL LP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, Polar Capital Holdings Plc, and DIMENSIONAL FUND ADVISORS LP. This page lists 143 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.